These protective effects complement any direct regenerative benefits
Sourcing and quality considerations Peptide quality significantly affects protocol outcomes
When to seek urgent medical advice : If you have already used an unlicensed peptide and experience any of the following, contact NHS 111 promptly or call 999 (or attend your nearest emergency department) in an emergency: Severe nausea, vomiting, or abdominal pain Signs of infection at the injection site (redness, swelling, warmth, or discharge) Dizziness, palpitations, or fainting Allergic reactions such as rash, swelling, or difficulty breathing (call 999 immediately for suspected anaphylaxis) Signs of serious infection or sepsis (high fever, confusion, rapid breathing, or feeling extremely unwell) Healthcare professionals are encouraged to take a non-judgemental approach when patients disclose use of unlicensed substances, focusing on harm reduction and signposting to regulated alternatives
BPC-157 is primarily studied for its potential to support tissue regeneration, angiogenesis, gastrointestinal health, and inflammation management
This study was approved by the local ethics committee
Abdominal Aorta Anastomosis in Rats and Stable Gastric Pentadecapeptide BPC 157, Prophylaxis and Therapy